The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential-Reference-Cited by-同舟云学术

The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential

Published:2018-10-25 Issue:10 Volume:13 Page:e0206158
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Friesen Westley J.^ORCID,Johnson Briana,Sierra Jairo,Zhuo Jin,Vazirani Priya,Xue Xiaojiao,Tomizawa Yuki,Baiazitov Ramil,Morrill Christie,Ren Hongyu,Babu Suresh,Moon Young-Choon,Branstrom Art,Mollin Anna,Hedrick Jean,Sheedy Josephine,Elfring Gary,Weetall Marla,Colacino Joseph M.,Welch Ellen M.,Peltz Stuart W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. A meta-analysis of nonsense mutations causing human genetic disease;M Mort;Hum Mutat,2008

2. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model;M Du;Proc Natl Acad Sci U S A,2008

3. Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects;CY Gregory-Evans;J Clin Invest,2014

4. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy;JN Miller;Hum Mol Genet,2015

5. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model;M Moosajee;Hum Mol Genet,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of TP53 nonsense mutations in cancer;Upsala Journal of Medical Sciences;2024-05-27

2. Composición química y actividad nefroprotectora de extractos hidroalcohólicos de hojas y rizomas de Smilax purhampuy R. del Ecuador;Salud, Ciencia y Tecnología;2024-04-24

3. From Polymeric Nanoformulations to Polyphenols—Strategies for Enhancing the Efficacy and Drug Delivery of Gentamicin;Antibiotics;2024-03-28

4. Synthesis of Gentamicins C1, C2, and C2a and Antiribosomal and Antibacterial Activity of Gentamicins B1, C1, C1a, C2, C2a, C2b, and X2;ACS Infectious Diseases;2023-07-23

5. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development;Biomolecules;2023-06-14